# Neurogene Inc.: Form 8-K, filed Jun 4, 2026

- Company: [Neurogene Inc.](/companies/ngne.md) (CIK 1404644)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:41 ET
- Period: 2026-06-03
- Accession: 0001404644-26-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/ngne-20260603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/ngne-20260603.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001404644-26-000040. Last ingested by Listed: Nov 10, 2026, 01:44 ET. No prices; not investment advice.
